1. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status—United States, January 22-October 3, 2020.;Zambrano;MMWR Morb Mortal Wkly Rep,2020
2. Maternal and neonatal outcomes of pregnant patients with coronavirus disease 2019 (COVID-19): a multistate cohort.;Metz;Am J Obstet Gynecol,2021
3. Pharmacometrics in pregnancy: an unmet need.;Ke;Annu Rev Pharmacol Toxicol,2014
4. Pfizer-BioNTech COVID-19 vaccine (BNT162, PF-07302048). Vaccines and Related Biological Products Advisory Committee briefing document. December 10, 2020. Accessed January 31, 2021. https://www.fda.gov/media/144246/download
5. ModernaTx Inc. Moderna COVID-19 vaccine. Vaccines and Related Biological Products Advisory Committee FDA briefing document. December 17, 2020. Accessed January 31, 2021. https://www.fda.gov/media/144434/download